Does OSIMERTINIB Cause Pleural effusion? 456 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 456 reports of Pleural effusion have been filed in association with OSIMERTINIB (TAGRISSO). This represents 1.6% of all adverse event reports for OSIMERTINIB.
456
Reports of Pleural effusion with OSIMERTINIB
1.6%
of all OSIMERTINIB reports
87
Deaths
222
Hospitalizations
How Dangerous Is Pleural effusion From OSIMERTINIB?
Of the 456 reports, 87 (19.1%) resulted in death, 222 (48.7%) required hospitalization, and 31 (6.8%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 456 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which OSIMERTINIB Alternatives Have Lower Pleural effusion Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN